For retail sale medicaments with other antibiotics market in Finland

Earlier Report Observations

From 2018 to 2024, the market for retail-packed other antibiotics in Finland experienced significant fluctuations. After remaining stable at around 188.2 million US dollars in 2018 and 188.1 million in 2019, the market volume rose to 191.2 million in 2020. A downward trend followed, with the market shrinking to 182.0 million in 2021 and further to a low of 158.6 million in 2022, before rebounding strongly to 186.0 million in 2023 and then moderating to 174.8 million in 2024.

Domestic production of these medicines showed general growth, increasing from 150.6 million US dollars in 2018 to a peak of 171.1 million in 2023, interrupted only by a drop to 144.4 million in 2022. Over the same period, imports contracted substantially from 39.4 million to 15.2 million, reducing the overall market supply despite the rise in local output. Exports remained a minor factor, growing from 1.8 million to 4.0 million by 2024.

The Finnish market operates within a framework of drug pricing and reimbursement oversight managed by Kela, which maintains an up-to-date database on medicine prices, reimbursement rates, and generic alternatives. This system influences consumer behavior and market dynamics by providing transparent information on treatment costs and available options.

Production for retail sale medicaments with other antibiotics in Finland

In value, 2017-2020, M $ US

Finland's production of retail sale medicaments containing other antibiotics grew for the second consecutive year. In 2020, output reached 167.3 million US dollars, marking a 2.4% increase from the previous year. Over the 2017-2020 period, production rose by 9.1%, with a compound annual growth rate of 2.9%. The lowest production value was recorded in 2018 at 150.6 million US dollars, which also saw the largest decline of 1.8%. In contrast, 2019 experienced the most significant increase at 8.5%.

Annual dynamics of production in Finland in value, 2017-2020, M $ US

Exports for retail sale medicaments with other antibiotics from Finland

Exports in kind, t

Export volumes showed considerable volatility during this period. The lowest exports were recorded in 2019 at 2.3 tonnes, which represented a 73.0% decline. In 2020, Finland's exports of retail sale medicaments containing other antibiotics surged to 33.4 tonnes, a remarkable 1,332.3% increase from 2019. This created a 14.3-fold difference between the peak in 2020 and the trough in 2019.

Annual dynamics of product's exports from Finland in kind, 2017-2020, t

From 2017 to 2020, the Netherlands was the leading destination for Finland's exports of retail sale medicaments containing other antibiotics by volume, accounting for 49.4% of total exports. Germany followed with 14.0%, and Denmark with 8.0%. Together, these three markets represented 71.4% of Finland's export flows in this category.

Structure of product's exports in kind by countries, 2017-2020

World map of product's exports from Finland in kind, 2017-2020

Exports in value, K $ US

Export values displayed notable fluctuations during these years. The lowest value was recorded in 2018 at 1,776 thousand US dollars, reflecting a 15.9% decline. In 2020, Finland's exports of retail sale medicaments containing other antibiotics reached 3,649 thousand US dollars, a substantial 97.0% increase from the previous year. This resulted in a 2.1-fold gap between the 2020 peak and the 2018 low.

Annual dynamics of product's exports from Finland in value, 2017-2020, K $ US

Throughout the 2017-2020 period, the Netherlands remained the primary market for Finland's exports of retail sale medicaments containing other antibiotics by value, capturing 39.8% of total exports. Sweden accounted for 14.0%, while Denmark represented 12.5%. Collectively, these three countries formed 66.3% of Finland's export value in this sector.

Structure of product's exports in value by countries, 2017-2020

World map of product's exports from Finland in value, 2017-2020

Imports for retail sale medicaments with other antibiotics to Finland

Imports in kind, t

Import volumes followed an unstable trajectory during this timeframe. The lowest imports were recorded in 2019 at 10.6 tonnes, which saw a dramatic 95.9% decrease. In 2020, Finland's imports of retail sale medicaments containing other antibiotics jumped to 125.9 tonnes, representing a sharp year-on-year increase of 1,086.3%. This created a 37-fold difference between the 2017 peak and the 2019 trough.

Annual dynamics of product's imports to Finland in kind, 2017-2020, t

Between 2017 and 2020, Poland was the largest source of Finland's imports of retail sale medicaments containing other antibiotics by volume, contributing 24.4% of total imports. Austria accounted for 20.2%, and Portugal for 14.2%. Together, these three countries supplied 58.8% of Finland's import volume in this category.

Structure of product's imports in kind by countries, 2017-2020

World map of product's imports to Finland in kind, 2017-2020

Imports in value, K $ US

After two consecutive years of decline, Finland's imports of retail sale medicaments containing other antibiotics by value showed a modest recovery. The lowest import value was recorded in 2019 at 26,592 thousand US dollars, which represented a 32.6% decrease. In 2020, imports reached 27,491 thousand US dollars, a slight 3.4% improvement from 2019. Over the entire 2017-2020 period, imports declined by 31.9%, with a compound annual growth rate of -12.0%.

Annual dynamics of product's imports to Finland in value, 2017-2020, K $ US

From 2017 to 2020, Finland's import structure for retail sale medicaments containing other antibiotics by value remained highly diversified. Switzerland was the largest supplier with 25.5% of import value, followed by France at 11.2% and Italy at 10.7%. Together, these three countries accounted for 47.3% of total imports, while numerous smaller markets made up the remaining 52.7%.

Structure of product's imports in value by countries, 2017-2020

World map of product's imports to Finland in value, 2017-2020